Published in Hepatitis Weekly, February 12th, 2001
Several research institutions have already delved into the use of these microspheres as adjuvant drug delivery mechanisms for a number of pharmaceuticals. One of the latest studies, performed in the Department of Biotechnological Engineering at Ben Gurion University of Negev, has tested the use of these HBsAg entrapped microscopic orbs on mice.
The group used two sizes of microencapsulated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.